The use of GnRH analogs in preserving ovarian function during chemotherapy
Abstract Background The literature has always been controversial on the use of gonadotropin-releasing hormone agonists in preserving fertility in women of childbearing age after chemotherapy; thereby, in this article, we will be discussing its use in preserving fertility. Main body of abstract When...
Main Authors: | Omar M. Odeh, Johnny Awwad, Dalia Khalife, Suleiman Ghunaim |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-11-01
|
Series: | Middle East Fertility Society Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43043-021-00088-x |
Similar Items
-
GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis
by: M.A.F. Youssef, et al.
Published: (2015-05-01) -
GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran
by: Ensieh Tehraninejad, et al.
Published: (2011-01-01) -
Use of gonadotropin-releasing hormone (GnRH) agonist trigger in fertility preservation for patients with inherited genetic disorders
by: Jamie Merkison, et al.
Published: (2022-09-01) -
Comparison of pregnancy outcomes between GnRH antagonist protocol with freeze-all strategy and long-acting GnRH agonist protocol in women with adenomyosis undergoing IVF/ICSI: a propensity-score matching analysis
by: Liting Zhang, et al.
Published: (2022-12-01) -
GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial
by: Francesco M. Fusi, et al.
Published: (2019-11-01)